Real-world outcomes with avelumab + axitinib in patients with advanced renal cell carcinoma in Japan: subgroup analyses from the J-DART2 study by International Metastatic Renal Cell Carcinoma Database Consortium risk classification
日本晚期肾细胞癌患者接受avelumab联合axitinib治疗的真实世界疗效:基于国际转移性肾细胞癌数据库联盟风险分级的J-DART2研究亚组分析
期刊:International Journal of Clinical Oncology
影响因子:2.8
doi:10.1007/s10147-024-02655-4
Furukawa, Junya; Kato, Taigo; Yamasaki, Toshinari; Monji, Keisuke; Tanaka, Toshiaki; Tsuchiya, Norihiko; Miyagawa, Tomoaki; Yaegashi, Hiroshi; Sano, Tomoyasu; Karashima, Takashi; Fujita, Kazutoshi; Hori, Jun-Ichi; Ito, Takayuki; Kajita, Masahiro; Tomita, Yoshihiko; Shinohara, Nobuo; Eto, Masatoshi; Oya, Mototsugu; Uemura, Hirotsugu